CORMEDIX INC (CRMD:NASDAQ)
$7.21 -0.03 (-0.4144%)
Analysed CORMEDIX INC (CRMD:NASDAQ) News Sources
Airway Therapeutics Appoints Biopharma Leader Joe Todisco to Board of Directors
13-04-2026
yahoo.com
How The CorMedix (CRMD) Story Is Shifting With Lower Guidance And Mixed Analyst Targets
08-04-2026
yahoo.com
CorMedix to Participate in Needham Virtual Healthcare Conference
07-04-2026
yahoo.com
Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength?
31-03-2026
yahoo.com
Do Options Traders Know Something About CorMedix Stock We Don't?
26-03-2026
yahoo.com
How The CorMedix (CRMD) Investment Story Is Shifting As Analyst Targets Reset
24-03-2026
yahoo.com
CorMedix CEO touts Melinta pivot, DefenCath TDAPA transition and Q2 REZZAYO Phase 3 data at Leerink
14-03-2026
marketbeat.com
CorMedix Touts Q2 REZZAYO Data, Melinta Integration and DefenCath Reimbursement Shift at Conference
14-03-2026
marketbeat.com
Assessing CorMedix (CRMD) Valuation After Recent Share Price Weakness And Growth Expectations
06-03-2026
yahoo.com
CorMedix Inc. Q4 2025 Earnings Call Summary
06-03-2026
moby.co
What is the current price of CORMEDIX INC (CRMD:NASDAQ)?
The current price of CORMEDIX INC (CRMD:NASDAQ) is $7.21.
CORMEDIX INC (CRMD:NASDAQ) absolute price change since previous trading day?
The absolute price change of CORMEDIX INC (CRMD:NASDAQ) since the previous trading day is $-0.03.
CORMEDIX INC (CRMD:NASDAQ) percentage price change since previous trading day?
The percentage price change of CORMEDIX INC (CRMD:NASDAQ) since the previous trading day is -0.4144%.
What is the most recent average sentiment score for CORMEDIX INC (CRMD:NASDAQ)?
The most recent average sentiment score for CORMEDIX INC (CRMD:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for CORMEDIX INC (CRMD:NASDAQ)?
The most recent sentiment for CORMEDIX INC (CRMD:NASDAQ) is .
SEC-8K** Filing Available For CORMEDIX INC (CRMD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.